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Abstract 
Studies have identified that serum-free hemoglobin subunits correlate positively with the severity of 
nonalcoholic fatty liver disease (NAFLD). However, the role of hemoglobin in the development of NAFLD 
remains unclear. In the present study, a rat model of NAFLD was developed, using a westernized diet high 
in saturated fat and refined sugar. Since a "westernized" diet is also high in red meat, we tested the effect 
of hemoglobin as a dietary source of heme in our model. Sprague-Dawley rats were fed ad libitum for 4 
weeks either control diet (7% fat), westernized diet (WD, 18% fat + 1% cholesterol), hemoglobin diet (7% 
fat + 2.5% Hb), or westernized and hemoglobin diet (18% fat + 1% cholesterol + 2.5% Hb). Rats fed WD 
developed features of NAFLD, including insulin resistance and accumulation of liver fatty acids in the 
form of triglycerides, increased lipid peroxidation (F2-Isoprostanes), and liver fibrotic marker 
(hydroxyproline). Hemoglobin consumption significantly influenced several biomarkers of NAFLD and 
hepatic biochemistry, suggesting a possible interaction with diet and/or liver lipid pathways. The complex 
mechanisms of interaction between WD and hemoglobin in our rat model warrants further studies to 
examine the role of dietary heme on NAFLD. 
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Studies have identified that serum-free hemoglobin subunits correlate positively with the severity of nonalcoholic fatty liver disease
(NAFLD). However, the role of hemoglobin in the development of NAFLD remains unclear. In the present study, a rat model of
NAFLD was developed, using a westernized diet high in saturated fat and refined sugar. Since a “westernized” diet is also high in
red meat, we tested the effect of hemoglobin as a dietary source of heme in our model. Sprague-Dawley rats were fed ad libitum
for 4 weeks either control diet (7% fat), westernized diet (WD, 18% fat + 1% cholesterol), hemoglobin diet (7% fat + 2.5% Hb),
or westernized and hemoglobin diet (18% fat + 1% cholesterol + 2.5% Hb). Rats fed WD developed features of NAFLD, including
insulin resistance and accumulation of liver fatty acids in the form of triglycerides, increased lipid peroxidation (F
2
-Isoprostanes),
and liver fibrotic marker (hydroxyproline). Hemoglobin consumption significantly influenced several biomarkers of NAFLD and
hepatic biochemistry, suggesting a possible interactionwith diet and/or liver lipid pathways.The complexmechanisms of interaction
between WD and hemoglobin in our rat model warrants further studies to examine the role of dietary heme on NAFLD.
1. Introduction
Nonalcoholic fatty liver disease (NAFLD) is increasingly rec-
ognized as the most common cause of chronic liver disease
in many industrialized and developing countries. It is esti-
mated to affect approximately 30% and 10–20% of adults
and children, respectively, in the USA and its prevalence is
increasing inmany countries where consumption of “western
diets,” high in fat, is rising [1]. Recently, a prospective
epidemiological study reported a significant incidence of
NAFLD in nonobese and nonaffluent populations in India
[2]. Interestingly, approximately 30%ofNAFLDpatients have
hyperferritinemia [3] and serum hemoglobin subunits 𝛼 and
𝛽 increase with severity of the disease in NAFLD patients [4–
6].
The prevailing concept of NAFLD is the “two hit” theory
that centers on the initial accumulation of fatty acids (FAs)
in the liver followed by a sequence of events associated
with oxidative stress, lipid peroxidation, and inflammation,
resulting in liver injury [7, 8]. However, the exact pathophys-
iological mechanisms are not fully understood. Therefore,
reliable animal models of NAFLD are important to identify
the relevant pathophysiology involved in the development of
NAFLD in order to develop effective therapeutic strategy.
Many groups have developed and studied experimental
models for NAFLD and nonalcoholic steatohepatitis (NASH)
using a variety of different high fat diets [9–11]. Evidence
indicates that not only the quantity, but also the types of
fat and the duration of feeding are important factors in the
development of an appropriate model of NAFLD [12–14].
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Table 1: (a) Composition of diets1. (b) Fatty acid composition of CD andWDanimal diets (means± SD) for 𝑛 = 5 animal pellet samples. Fatty
acid levels in heme supplemented diets (HbD and W + HbD) were not statistically different to their non-heme comparable diet. 𝑃 < 0.001
for all fatty acids in WD versus CD.
(a)
Diet CD WD HbD W + HbD
Product NO. SF07-034 SF07-079 SF07-078 SF07-080
Total fats (%) 7 18 + 1 7 18 + 1
Source Canola oil Ghee + cholesterol Canola oil Ghee + cholesterol
Hb (%) — — 2.5 2.5
Total Fe (mg/Kg) 70 59 144 144
Energy from lipids (%) 15.8 35.0 15.8 35.0
Protein (%) 19.4 19.4 19.4 19.4
Starch (%) 55.0 18.9 55.0 18.9
Sucrose (%) 10.0 34.0 10.0 34.0
Crude fiber (%) 4.7 4.7 4.7 4.7
Digestible energy (MJ/Kg) 16.5 19.0 16.6 19.0
1Detailed information on these animal diets is available from Specialty Feeds Pty Ltd (http://specialtyfeeds.com/data/sf07-034.html).
(b)
Diet CD WD
FA (ng/mg diet)
Caprylic acid (8 : 0) 27.62 ± 2.8 187.96 ± 20.3
Capric acid (10 : 0) 58.44 ± 4.7 661.27 ± 42.7
Lauric acid (12 : 0) 568.77 ± 190.6 825.26 ± 95.2
Myristic acid (14 : 0) 184.10 ± 19.1 2301.15 ± 100.7
Palmitic acid (16 : 0) 1353.18 ± 484.4 5392.81 ± 319.2
Palmitoleic acid (16 : 1) 18.76 ± 4.2 144.87 ± 9.6
Margaric acid (17 : 0) 14.87 ± 5.4 94.48 ± 8.0
Stearic acid (18 : 0) 868.01 ± 322.9 2019.55 ± 205.4
Oleic acid (18 : 1) 2943.43 ± 1020.2 1930.05 ± 148.8
Linoleic acid (18 : 2) 363.65 ± 108.9 80.67 ± 4.4
Linolenic acid (18 : 3) 329.74 ± 97.7 55.28 ± 3.3
This study aims to firstly examine the effect of a westernized
diet containing cholesterol, ghee, and refined sugar on the
development of NAFLD pathophysiology in a rat model.
Ghee is rich in saturated fats (SFs) and cholesterol with
a similar fatty acid profile to typical human high fat diets
[15]. “Westernized diets” are generally high in red meats, a
major source of cholesterol and saturated fat which may
contribute to the increased risk of diabetes and cardiovascular
disease [16]. Red meat is also a rich source of iron and heme,
potential prooxidants and catalysts of peroxidative damage
under certain circumstances [17, 18]. However, some in vitro
studies on hemoglobin have reported protective properties
against oxidative injury [19–21] and hemoglobin has not been
previously investigated in vivo in the context of NAFLD. We
therefore studied the role of hemoglobin in the development
of NAFLD.
2. Material and Methods
2.1.Materials. All reagents usedwere purchased from Sigma-
Aldrich (St. Louis, MO) unless otherwise stated. Hemoglobin
(Ferrohemoglobin) was from MP Biomedicals (NSW, Aus-
tralia). Myristic acid (1,2,3-13C
3
) from Cambridge Isotope
Laboratories (Andover, MA). Arachidonic acid and F
2
-iso-
prostanes were from Cayman Chemical (Ann Arbor, MI).
2.2. Animals and Diets. Male Sprague-Dawley rats, 5 weeks
old (150 g, 𝑛 = 20), were purchased from Comparative Medi-
cine Centre for Animal Resources (CM-CARE), Singapore.
Rats were housed randomly 2 per cage and were allowed
water ad libitum in an animal facility with a 12 h light-dark
cycle. Groups were fed either (1) control diet (CD, SF07-
034), a semipure diet formulation based on AIN-93G with
7% fat content from canola oil; (2) westernized diet (WD,
SF07-079) where canola oil was replaced with 18% ghee and
1% cholesterol; (3) high hemoglobin diet (HbD, SF07-078)
supplemented with 2.5% hemoglobin; and (4) westernized
and hemoglobin diet (W + HbD, SF07-080) with 18% ghee,
1% cholesterol and 2.5% hemoglobin (Table 1(a), Glen Forest
Specialty Feed, WA). The protocol was approved by the
National University of Singapore Institutional Animal Care
and Use Committee (IACUC). Animals were euthanized
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and excised livers were weighed, washed with phosphate-
buffed saline (PBS, 4∘C) and snap-frozen in liquid nitrogen
and stored at −80∘C. Plasma was prepared from collected
venous blood by centrifugation and then stored at −80∘C
with butylated hydroxytoluene (BHT, 20𝜇M). Livers were
scored for their fatty, pale appearance. (1 = normal;) 5 =
complete pale, white complexion.
2.3. Plasma Insulin and Alanine Transaminase (ALT) Mea-
surement. Plasma insulin levels and ALT activity were deter-
mined using a rat insulin ELISA kit (cat no. EZRMI-13K,
Millipore, Billerica, MA) and alanine transaminase activity
kit (cat no. 700260, Cayman Chemical, Ann Arbor, MI),
respectively, according to the manufacturer’s protocol.
2.4. Direct Determination of Liver Triglycerides. Liver triglyc-
erides were determined as described in [22].
2.5. Hydroxyproline Content in Rat Livers. Hepatic hydrox-
yproline (HP) was measured as an index of collagen con-
tent in liver using a method described by Woessner [23].
Briefly, 100 𝜇L of liver homogenate was hydrolyzed in an
airtight glass tube by HCl (final concentration, 6M) for
3 h at 130∘C. pH of hydrolyzed sample was adjusted to pH
6.0-7.0 with NaOH (10M). Hydroxyproline oxidation was
initiated by adding chloramine T solution (0.05M) and
incubation for 20min at 22∘C. Excess chloramine T was
removed by adding perchloric acid (3.15M) for 5min. Finally,
p-dimethylaminobenzaldehyde solution (20%) was added,
vortexed and incubated for 20min at 60∘C. Absorbance was
determined spectrophotometrically at 557 nm and hydrox-
yproline content of liver samples were determined directly
from a freshly prepared hydroxyproline standard curve.
2.6. Lipid Extraction and Alkaline Saponification for FA
Analysis. 100 𝜇L of liver homogenates (1mg/mL) or 2mg
of crushed animal chow was weighed into glass tubes and
hydrolyzed with concentrated HCl (8M, 0.5mL) for 1 h at
80∘C. 200𝜇L of pyrogallol (50mg/mL) was added to mini-
mize oxidation. Liver homogenates were adjusted to pH 5-
6 after hydrolysis using NaOH (10M) in the presence of
K
2
HPO
4
buffer (1M, pH9). Lipid was extracted with 5mL
of ice-cold Folch extraction solvent (chloroform :methanol
2 : 1, 0.005%BHT).The samples were centrifuged at 3000 rpm
for 2min and 0.5mL of extraction solvent was carefully
transferred into a glass vial. 10 𝜇L (200 ng) of heavy labelled
myristic acid was added and samples were dried under N
2
gas. Samples were resuspended in 0.5mL of PBS and pH was
adjusted to 13 with KOH (1M) and saponified at 20∘C with
shaking at 75 rpm for 15 h in the dark. The pH was adjusted
to 5 with HCl (5M) in the presence of 0.5mL of acetate
acid buffer (0.4M, pH4) followed by Folch solvent (1mL) for
15min at 20∘C. The organic phase was extracted and dried
under a stream ofN
2
gas and derivatizated at 50∘C for 1 hwith
50𝜇L of 1 : 1 BSTFA + 1% TMCS and acetonitrile.
2.7. Gas Chromatography-Mass Spectrometry (GC-MS) FA
Analysis. FAs were analyzed using a Hewlett-Packard 5973
mass selective detector interfaced with a Hewlett-Packard
5890II gas chromatograph. Separations were carried out on a
fused silica capillary column (30m× 0.2mm i.d.) coatedwith
cross-linked 5% phenylmethylsiloxane (0.33 𝜇m) (Ultra2,
Agilent, J & W Scientific). The quadrupole and ion source
of the MS were maintained at 150 and 230∘C, respectively.
Derivatized samples (1 𝜇L) were injected with a 10 : 1 split
into the GC injection port (280∘C). Column temperature
was increased from 80 to 230∘C at 47.5∘C/min after 1min at
80∘C and then increased to 235∘C at 1∘C/min and held for
2min. The temperature was further increased to 280∘C at
50∘C/min and held for 0.5min and then raised to 300∘C at
50∘C/min and held for 1.5min. The carrier gas was helium
with a flow rate of 0.8mL/min (average velocity = 55 cm/s).
Selected-ion monitoring was performed using the electron
ionization mode at 70 eV to monitor one target ion and two
or more qualifier ions selected from each compound’s mass
spectrum to optimize sensitivity and specificity. Relative
molar response factors for each analyte were calculated using
calibration curves constructed from six different concentra-
tions in triplicate of FAs and showed good linearity (𝑟2 >
0.95).
2.8. GC-MSQuantification of Total ArachidonicAcid andTotal
Cholesterol. Lipid extractions for the analysis of arachidonic
acid, cholesterol, and F
2
-isoprostanes of liver samples using
GC-MS were performed as described by Jenner et al. [24].
2.9. Statistical Analysis. Differences between means were
evaluated using a one-way analysis of variance (ANOVA)
followed by Bonferroni post hoc test for multigroup analysis
(∗𝑃 < 0.05 versus CD, ∗∗𝑃 < 0.01 versus CD, ∗∗∗𝑃 < 0.001
versus CD, #𝑃 < 0.05 versus WD, ##𝑃 < 0.01 versus WD,
$
𝑃 < 0.05 versus HbD, $$$𝑃 < 0.001 versus HbD considered
as significant).
3. Results
3.1. Body and LiverWeights. Rats fed awesternized diet (WD)
for 4 weeks showed a trend of higher body and liver weights,
but this was not statistically significant compared to control
diet (CD, Table 2). Growth rate of the rats in each group did
not differ significantly from each other (data not shown).
Livers from rats fed diets enriched in fat appeared white and
fatty (scale 5) compared to normal livers (scale 1) of CD and
hemoglobin diet (HbD) fed rats.The presence of heme inWD
reduced the fatty appearance of rat livers (scale 3).
3.2. FA Profile of Animal Diets. As expected, WD supple-
mentedwith ghee contained increased levels of saturated fatty
acids (SFAs) such as palmitic, myristic, stearic, and capric
acids. In the CD and HbD comprising canola oil, we found
more oleic, linoleic and linolenic acids (Table 1(b)). Using the
GC-MS for FA analysis, the recovery of total FAs in animal
chow and liver tissue was calculated to be 80.2–86.0%.
3.3.WD IncreasesHepatic FA andTriglyceride Levels. GC-MS
analysis confirmed the accumulation of FAs in rat livers as
4 ISRN Oxidative Medicine
Table 2: Weights of animals and livers, plasma ALT activity, liver triglyceride, cholesterol and F2-isoprostanes levels and appearance of liver
after 4 weeks of feeding1.
Diet CD WD HbD W + HbD
Body wt (g) 431 ± 28 469 ± 26 407 ± 59 487 ± 72
Liver wt (% bodywt) 4.3 ± 0.5 4.8 ± 0.4 4.0 ± 0.4 4.5 ± 0.5
Plasma ALT activity (U/mL, fold change) 1.0 ± 0.3 1.69 ± 0.9 0.65 ± 0.2 0.64 ± 0.3#
Liver triglycerides (mg/g liver) 5.0 ± 0.4 21.0 ± 2.0∗∗∗ 5.2 ± 0.5 17.8 ± 1.9∗∗∗#$$$
Liver cholesterol (mg/g liver) 2.05 ± 0.3 2.33 ± 0.3 1.77 ± 0.4 2.02 ± 0.3
Liver F2-isoprostanes (pg/𝜇gAA) 7.5 ± 1.2 15.7 ± 2.5
∗∗∗
9.6 ± 2.5 13.7 ± 2.2
∗∗
Appearance of liver2 1 5 1 3
1Data are expressed as means ± SD for 𝑛 = 5 rats. 2For appearance of liver, 1: healthy normal, 5: fatty and white. ∗∗𝑃 < 0.01, ∗∗∗𝑃 < 0.001 versus CD, $$$𝑃 <
0.001 versus HbD, #𝑃 < 0.05 versus WD. ALT; alanine transaminase.
Table 3: FA profile of rat livers1.
Diet CD WD HbD W + HbD 𝑃
FA (ng/mg protein)
Caprylic acid (8 : 0) 137 ± 21 201 ± 20∗ 155 ± 34 138 ± 18# <0.05
Capric acid (10 : 0) 169 ± 30 414 ± 35∗∗ 195 ± 41 225 ± 48## <0.01
Lauric acid (12 : 0) 1837 ± 330 2715 ± 457∗∗ 1906 ± 266 2199 ± 374 <0.01
Myristic acid (14 : 0) 959 ± 395 3379 ± 567∗∗ 875 ± 387 1697 ± 285## <0.01
Palmitic acid (16 : 0) 11799 ± 2943 37621 ± 10131∗∗ 9166 ± 1447 17181 ± 3319## <0.01
Palmitoleic acid (16 : 1) 856 ± 400 7419 ± 2863∗∗ 426 ± 165 2726 ± 565## <0.01
Margaric acid (17 : 0) 110 ± 34 436 ± 47∗∗ 102 ± 27 252 ± 24## <0.01
Stearic acid (18 : 0) 8741 ± 623 10360 ± 1079 8327 ± 917# 10031 ± 812 <0.05
Oleic acid (18 : 1) 6881 ± 3257 30407 ± 9897∗∗ 4513 ± 1210 12578 ± 4198## <0.01
Linoleic acid (18 : 2) 894 ± 252 1543 ± 361 678 ± 52## 961 ± 153 <0.01
Linolenic acid (18 : 3) 207 ± 74 212 ± 54 170 ± 87 120 ± 41 =0.087
Docosahexaenoic acid (22 : 6) 1866 ± 220 3557 ± 553∗∗ 1358 ± 448 2066 ± 402## <0.01
1Data are expressed as means ± SD for 𝑛 = 5 rat livers. ∗𝑃 < 0.05 versus CD, ∗∗𝑃 < 0.01 versus CD #𝑃 < 0.05 versus WD, ##𝑃 < 0.01 versus WD are
significantly different.
shown in Table 3. Significant differences (𝑃 < 0.01 and 𝑃 <
0.05) were observed in livers ofWD-fed rats compared to CD
in all FAs measured except stearic acid (18 : 0), linoleic acid
(18 : 2) and linolenic acid (18 : 3). HbD did not significantly
alter the FA profile compared to CD. However, the presence
of Hb with WD significantly reduced hepatic accumulation
of FAs compared to WD with the exception of lauric,
stearic, linoleic, and linolenic acids. Liver triglycerides (TGs)
increased in rats fed WD and W + HbD compared to CD
(Table 2, 𝑃 < 0.001), whilst WD with added heme reduced
liver TGs compared to WD alone (𝑃 < 0.05).
3.4. WD Increases Liver F
2
-Isoprostanes, Plasma Insulin Level
and Alanine Transaminase (ALT) Activity. Liver F
2
-isopros-
tanes and plasma insulin concentrations of the rats fed the
WD were significantly higher than those of the rats fed
CD (Table 2, Figure 1(a)). W + HbD showed a trend of
decreasing liver F
2
-isoprotanes and plasma insulin levels
compared toWD, but neither were statistically significant.W
+ HbD significantly reduced plasma ALT activity compared
to WD alone, although the increase of plasma ALT activity
byWD alone was statistically not significant compared to CD
(Table 2).
3.5. Liver Total Iron, Heme, and Hydroxyproline Content.
Compared to CD,WD andHbD did not affect liver total iron
content whilst W + HbD rat livers were significantly higher
compared to HbD (Figure 1(b)). In contrast, liver heme
content increased with HbD compared to CD, whilst other
diets were not significantly different (Figure 1(c)). There was
a significant increase in liver collagen levels as determined
by hydroxyproline contents in rats fed with WD compared
to CD (Figure 1(c)). However, liver HP level was reduced
significantly in W + HbD compared to WD.
4. Discussion
Several experimental animal models have been developed to
study the mechanisms responsible for the onset of NAFLD
and NASH [25]. Diets rich in polyunsaturated and/or mo-
nounsaturated fatty acids are generally accepted to offer a
beneficial effect on insulin sensitivity as compared to SFAs
[26, 27]. However, several animal studies demonstrate that
excess intake of “good” unsaturated fats can actually be
detrimental, highlighting the importance of the amount and
duration of fat feeding in the development of aNAFLDmodel
[9–11].
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Figure 1: Plasma insulin, hepatic total iron, heme and hydroxyproline contents in rats. Rats were fed CD,WD,HbD andW+HbD for 4 weeks
ad libitum. (a) WD increases plasma insulin levels in rats compared to CD. This effect was attenuated in W + HbD fed rats. (b) Total iron
content was elevated in liver of animals on W + HbD compared to HbD. (c) Liver heme and (d) hydroxyproline content were increased in
animals on HbD and WD, respectively compared to CD. Data are means ± SD for 𝑛 = 4-5 samples. CD: control diet, WD: westernized diet,
HbD: hemoglobin diet, W + HbD: westernized and hemoglobin diet. ∗𝑃 < 0.05 versus CD, #𝑃 < 0.05 versus WD, $𝑃 < 0.05 versus HbD.
a.u.: arbitrary unit.
A typical “westernized diet” is rich in SFAs and cholesterol
and provides about 35–40% energy from fat [26]. GC-MS
analysis of FA composition in our WD confirmed that using
ghee as an alternative to plant oil provided a more phys-
iologically relevant “westernized diet” in SFA content and
fat derived energy. Detailed GC-MS FA profiling of diets is
highly beneficial and often not performed or reported in
previous NAFLD animal studies. Further GC-MS analysis
ensured that WD quality was maintained throughout the
4 week study and that our storage conditions (4∘C under
vacuum) prevented FA oxidation. Lipid is susceptible to
oxidation under poor storage environments and the presence
of lipid peroxidation products is highly undesirable due to
their complex biological and pathophysiological activities,
which can confound the interpretation of these feeding
studies [28].
Initial development of NAFLD is believed to involve hep-
atic lipid accumulation, commonly referred to as the first hit
in the “two hit” hypothesis ofNAFLD [7]. Feeding overweight
nondiabetic subjects a high fat diet for 10 days has been
shown to increase liver fat content by 35% [29]. In patients
with NAFLD, dietary fat intake accounted for about 15% of
intrahepatic lipid accumulation [30]. In our study, feeding
rats with a WD produced fatty livers and significantly
increased levels of liver FAs, mostly stored as TGs, satisfying
a fundamental criterion on NAFLD. Insulin resistance in
WD rats of our study, indicated by significantly raised
plasma insulin, is likely to be the consequence of hepatic
FA accumulation [31–33]. Interestingly, WD did not result
in significantly elevated hepatic cholesterol levels, which may
be due to different regulation of separate metabolic pathways
that control hepatic uptake, synthesis, storage and export of
6 ISRN Oxidative Medicine
cholesterol compared to FAs. It is well documented that rats
fed high cholesterol diets are less prone to hypercholes-
terolemia than other animal models [24, 34–36].
The second hit inNAFLD involvesmultiple effects arising
from oxidative stress and lipid peroxidation. Lettéron and
colleagues have shown that hepatocytes with accumulated fat
are susceptible to lipid peroxidation [37]. Oxidized choles-
terol has been shown to contribute to the development of
atherosclerosis in ApoE and Ldl receptor-deficient mice [38].
Accumulation of F
2
-isoprostanes and collagen content (mea-
sured as hydroxyproline content) provides further evidence
of oxidative stress in this model.
Recently, several groups have reported that serum levels
of free hemoglobin 𝛼 and free hemoglobin 𝛽 reflect the
severity of NAFLD and thus provide an additional biomarker
for the disease [4–6]. Moreover, significant changes in iron
metabolism have been associated with NAFLD. Approxi-
mately 30% of NAFLD patients have hyperferritinemia [3]
and; interestingly, iron depletion by phlebotomy treatment
reduced features of NAFLD [39]. Conversely, impairment of
iron sensing or regulatory proteins has an opposite effect
on iron depletion in NAFLD patients [40]. The effect of
dietary hemoglobin was complex but important differences
were observed in W + HbD compared to WD. Intriguingly,
our data in WD rats suggest a possible “protective” effect of
dietary hemoglobin on livers by decreasing FA and TG accu-
mulation, collagen content, plasma ALT activity and insulin
levels.Themechanism of these effects is unclear, but suggests
that dietary hemoglobin does not elicit a direct “proox-
idant” activity in the liver. Indeed, liver F
2
-isoprostanes
(the gold standard biomarker of lipid peroxidation) were
unaffected by addition of heme to our diets. Liu et al.
reported increased expression of hemoglobin subunits in
HepG2 and HEK293 cells upon hydrogen peroxide challenge
and hemoglobin overexpression suppressed oxidative stress
inHepG2 cells [19].Others have also showed that hemoglobin
has antioxidative functions under different conditions [20,
21]. Our data suggests that dietary fatmay influence processes
that control hepatic levels of heme and iron, in particular
elevating iron at the expense of heme. Moreover, rabbits
on a high cholesterol diet displayed microvascular damage
associated with iron accumulation and lipid peroxidation
in the liver [36]. The possibility that the quantity and
type of dietary fat have different effects on the uptake,
metabolism and transport of heme and/or iron, merits
more detailed investigations to examine potential associated
mechanisms.
In conclusion, a relevant NAFLD animal model was
established through feeding rats a diet containing increased
levels of saturated fat and refined sugar. This animal model
displayed evidence of increased fat accumulation in liver,
insulin resistance, and mild oxidative stress with elevated
F
2
-isoprostanes and collagen deposition. Another advantage
of the current study was that rats retained their voluntary
oral feeding patterns with the WD. Supplementation of
hemoglobin in WD indicates that dietary heme does not
promote NAFLD or liver oxidative stress. We believe that
this animal model provides a useful tool to elucidate the
mechanisms underlying the development of NAFLD.
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